← Back to Session

Time Completed: 01:04:43

Final Score 49%

89
91

Questions

  • Q1. Correct
  • Q2. X Incorrect
  • Q3. X Incorrect
  • Q4. Correct
  • Q5. Correct
  • Q6. Correct
  • Q7. X Incorrect
  • Q8. Correct
  • Q9. X Incorrect
  • Q10. X Incorrect
  • Q11. X Incorrect
  • Q12. Correct
  • Q13. Correct
  • Q14. X Incorrect
  • Q15. Correct
  • Q16. Correct
  • Q17. Correct
  • Q18. X Incorrect
  • Q19. Correct
  • Q20. Correct
  • Q21. Correct
  • Q22. Correct
  • Q23. Correct
  • Q24. X Incorrect
  • Q25. X Incorrect
  • Q26. X Incorrect
  • Q27. X Incorrect
  • Q28. Correct
  • Q29. X Incorrect
  • Q30. Correct
  • Q31. X Incorrect
  • Q32. X Incorrect
  • Q33. X Incorrect
  • Q34. X Incorrect
  • Q35. X Incorrect
  • Q36. Correct
  • Q37. Correct
  • Q38. X Incorrect
  • Q39. Correct
  • Q40. Correct
  • Q41. Correct
  • Q42. X Incorrect
  • Q43. X Incorrect
  • Q44. Correct
  • Q45. Correct
  • Q46. Correct
  • Q47. Correct
  • Q48. Correct
  • Q49. X Incorrect
  • Q50. Correct
  • Q51. X Incorrect
  • Q52. X Incorrect
  • Q53. X Incorrect
  • Q54. Correct
  • Q55. X Incorrect
  • Q56. Correct
  • Q57. X Incorrect
  • Q58. X Incorrect
  • Q59. Correct
  • Q60. Correct
  • Q61. Correct
  • Q62. Correct
  • Q63. Correct
  • Q64. X Incorrect
  • Q65. Correct
  • Q66. X Incorrect
  • Q67. Correct
  • Q68. X Incorrect
  • Q69. X Incorrect
  • Q70. X Incorrect
  • Q71. X Incorrect
  • Q72. X Incorrect
  • Q73. X Incorrect
  • Q74. X Incorrect
  • Q75. Correct
  • Q76. Correct
  • Q77. X Incorrect
  • Q78. X Incorrect
  • Q79. Correct
  • Q80. Correct
  • Q81. Correct
  • Q82. Correct
  • Q83. Correct
  • Q84. Correct
  • Q85. X Incorrect
  • Q86. X Incorrect
  • Q87. X Incorrect
  • Q88. Correct
  • Q89. X Incorrect
  • Q90. X Incorrect
  • Q91. X Incorrect
  • Q92. Correct
  • Q93. Correct
  • Q94. Correct
  • Q95. Correct
  • Q96. X Incorrect
  • Q97. Correct
  • Q98. Skipped
  • Q99. Correct
  • Q100. X Incorrect
  • Q101. X Incorrect
  • Q102. Correct
  • Q103. X Incorrect
  • Q104. Correct
  • Q105. Correct
  • Q106. X Incorrect
  • Q107. X Incorrect
  • Q108. Correct
  • Q109. Correct
  • Q110. X Incorrect
  • Q111. Correct
  • Q112. X Incorrect
  • Q113. Correct
  • Q114. Correct
  • Q115. Correct
  • Q116. X Incorrect
  • Q117. X Incorrect
  • Q118. X Incorrect
  • Q119. Correct
  • Q120. X Incorrect
  • Q121. Correct
  • Q122. X Incorrect
  • Q123. X Incorrect
  • Q124. X Incorrect
  • Q125. Correct
  • Q126. X Incorrect
  • Q127. X Incorrect
  • Q128. X Incorrect
  • Q129. Correct
  • Q130. X Incorrect
  • Q131. X Incorrect
  • Q132. X Incorrect
  • Q133. X Incorrect
  • Q134. Correct
  • Q135. Correct
  • Q136. X Incorrect
  • Q137. X Incorrect
  • Q138. X Incorrect
  • Q139. Correct
  • Q140. X Incorrect
  • Q141. Correct
  • Q142. X Incorrect
  • Q143. X Incorrect
  • Q144. X Incorrect
  • Q145. Correct
  • Q146. X Incorrect
  • Q147. Correct
  • Q148. X Incorrect
  • Q149. Correct
  • Q150. X Incorrect
  • Q151. Correct
  • Q152. X Incorrect
  • Q153. Correct
  • Q154. X Incorrect
  • Q155. X Incorrect
  • Q156. Correct
  • Q157. Correct
  • Q158. Correct
  • Q159. X Incorrect
  • Q160. Correct
  • Q161. X Incorrect
  • Q162. Correct
  • Q163. Correct
  • Q164. Correct
  • Q165. Correct
  • Q166. X Incorrect
  • Q167. Correct
  • Q168. Correct
  • Q169. X Incorrect
  • Q170. X Incorrect
  • Q171. Correct
  • Q172. X Incorrect
  • Q173. Correct
  • Q174. Correct
  • Q175. X Incorrect
  • Q176. X Incorrect
  • Q177. X Incorrect
  • Q178. Correct
  • Q179. X Incorrect
  • Q180. Correct

Pharmacology

Infections

Question 69 of 180

Regarding cephalosporin antibiotics, which of the following statements is INCORRECT:

Answer:

The principal side effect of the cephalosporins is hypersensitivity. Patients with a history of anaphylaxis, urticaria, or rash immediately after penicillin use should not receive a penicillin or other beta-lactam antibiotics; about 0.5 – 6.5 % of penicillin-sensitive patients will also be allergic to the cephalosporins.

Cephalosporins

Mechanism of Action

The cephalosporins are broad-spectrum beta-lactam antibiotics that attach to penicillin binding proteins to interrupt cell wall synthesis, leading to bacterial cell lysis and death.

They are used for the treatment of septicaemia, pneumonia, meningitis, biliary tract infections, peritonitis, and urinary tract infections. Cephalosporins penetrate the cerebrospinal fluid poorly unless the meninges are inflamed; cefotaxime and ceftriaxone are suitable cephalosporins for infections of the CNS (e.g. meningitis).

Side Effects

The principal side effect of the cephalosporins is hypersensitivity. Patients with a history of anaphylaxis, urticaria, or rash immediately after penicillin use should not receive a penicillin or other beta-lactam antibiotics; about 0.5 – 6.5 % of penicillin-sensitive patients will also be allergic to the cephalosporins.

Gastrointestinal effects such as diarrhoea, nausea and vomiting are common with cephalosporins. Antibiotic-associated colitis may occur, more commonly with second- and third-generation cephalosporins.

Cefalexin

The orally active first generation cephalosporin, cefalexin is useful for urinary tract infections which do not respond to other drugs or which occur in pregnancy, respiratory tract infections, otitis media, sinusitis, and skin and soft-tissue infections.

Cefuroxime

The second generation cephalosporin, cefuroxime is less susceptible than the earlier cephalosporins to inactivation by beta-lactamases. It is therefore active against certain bacteria which are resistant to the other drugs and has greater activity against Haemophilus influenzae.

Cefuroxime is indicated first line for community acquired septicaemia, early-onset hospital acquired pneumonia and acute pyelonephritis.

Cefotaxime and Ceftriaxone

The third generation cephalosporins, cefotaxime and ceftriaxone have greater activity than the second generation cephalosporins against certain Gram-negative bacteria e.g. N. gonorrhoeae, N. meningitidis. However, they are less active than cefuroxime against Gram-positive bacteria, most notably Staphylococcus aureus. Their broad antibacterial spectrum may encourage superinfection with resistant bacteria or fungi (e.g. C. difficile colitis).

Cefotaxime (or ceftriaxone) are indicated first line in:

  • Blind treatment of meningitis in patients > 3 months (with amoxicillin if patient > 50 years)
  • Meningitis caused by meningococci
  • Meningitis caused by pneumococci
  • Meningitis caused by H. influenzae
  • Severe or invasive salmonellosis
  • Typhoid fever
  • Gonorrhoea
  • Gonococcal arthritis
  • Haemophilus influenzae epiglottitis

Ceftriaxone has a longer half-life and therefore needs to be given only once daily. The calcium salt of ceftriaxone forms a precipitate in the gallbladder which may rarely cause symptoms but these usually resolve when the antibiotic is stopped.

Report A Problem

Is there something wrong with this question? Let us know and we’ll fix it as soon as possible.

Loading Form...

Close
  • Biochemistry
  • Blood Gases
  • Haematology
Biochemistry Normal Value
Sodium 135 – 145 mmol/l
Potassium 3.0 – 4.5 mmol/l
Urea 2.5 – 7.5 mmol/l
Glucose 3.5 – 5.0 mmol/l
Creatinine 35 – 135 μmol/l
Alanine Aminotransferase (ALT) 5 – 35 U/l
Gamma-glutamyl Transferase (GGT) < 65 U/l
Alkaline Phosphatase (ALP) 30 – 135 U/l
Aspartate Aminotransferase (AST) < 40 U/l
Total Protein 60 – 80 g/l
Albumin 35 – 50 g/l
Globulin 2.4 – 3.5 g/dl
Amylase < 70 U/l
Total Bilirubin 3 – 17 μmol/l
Calcium 2.1 – 2.5 mmol/l
Chloride 95 – 105 mmol/l
Phosphate 0.8 – 1.4 mmol/l
Haematology Normal Value
Haemoglobin 11.5 – 16.6 g/dl
White Blood Cells 4.0 – 11.0 x 109/l
Platelets 150 – 450 x 109/l
MCV 80 – 96 fl
MCHC 32 – 36 g/dl
Neutrophils 2.0 – 7.5 x 109/l
Lymphocytes 1.5 – 4.0 x 109/l
Monocytes 0.3 – 1.0 x 109/l
Eosinophils 0.1 – 0.5 x 109/l
Basophils < 0.2 x 109/l
Reticulocytes < 2%
Haematocrit 0.35 – 0.49
Red Cell Distribution Width 11 – 15%
Blood Gases Normal Value
pH 7.35 – 7.45
pO2 11 – 14 kPa
pCO2 4.5 – 6.0 kPa
Base Excess -2 – +2 mmol/l
Bicarbonate 24 – 30 mmol/l
Lactate < 2 mmol/l

Join our Newsletter

Stay updated with free revision resources and exclusive discounts

©2017 - 2024 MRCEM Success